Doctor Oldenburg discusses cannabis regulations and patient care in Nebraska commission hearing

In a pivotal meeting held on May 23, 2025, the Nebraska Legislature's General Affairs Committee engaged in a robust discussion about the future of medical cannabis in the state. The atmosphere was charged with a mix of hope and caution as lawmakers and medical professionals explored the implications of recent legislative changes regarding cannabis use for medical purposes.

Dr. Oldenburg, a physician with extensive experience in pain management, emphasized the importance of research in shaping medical practices. Drawing from her experiences in Colorado, she highlighted the need for a careful and deliberate approach to cannabis regulation, particularly in light of the opioid crisis that has reshaped pain management strategies across the country. "We need to seize the opportunity to be slow and deliberate in how we designate appropriate conditions for medical cannabis," she stated, advocating for a research-driven framework that prioritizes patient safety.

The committee members probed Dr. Oldenburg about her views on the regulation of cannabis, particularly concerning the conditions under which it might be prescribed. She expressed a belief in the potential benefits of cannabis for specific ailments but cautioned against a broad, unrestricted approach. "We don't just say, yep, everybody gets this. It's not a shotgun approach," she remarked, underscoring the necessity for targeted research and regulation.

Senator Klaus raised concerns about the experiences in Colorado, where the rapid evolution of cannabis laws led to challenges in regulation and public health. Dr. Oldenburg acknowledged these issues, noting that while Colorado was a pioneer in cannabis legislation, it also faced significant hurdles due to insufficient regulations. "We have the opportunity now to learn from their mistakes," she said, advocating for a more structured approach in Nebraska.

As the discussion unfolded, the committee also addressed the potential for different methods of cannabis administration, with Dr. Oldenburg expressing her bias against smoking due to its known health risks. "I'm a physician, so I spend every day telling people not to smoke," she explained, emphasizing the need for safer alternatives in medical cannabis delivery.

The meeting concluded with a sense of urgency and responsibility among lawmakers and medical professionals alike. As Nebraska navigates the complexities of integrating medical cannabis into its healthcare system, the emphasis remains on ensuring that regulations are informed by scientific research and public health considerations. The path forward is fraught with challenges, but the commitment to a thoughtful and informed approach could pave the way for a more effective and responsible medical cannabis program in the state.